Medical News

RSS

Cetaphil launches Restoraderm for management of eczema and atopic dermatitis skin

The Cetaphil® brand, the #1 dermatologist-recommended brand of cleansers and moisturizers announced the launch of Cetaphil® Restoraderm® products, formulated specifically for the needs of eczema and atopic dermatitis skin. Cetaphil® Restoraderm® Skin Restoring Body Wash and Skin Restoring Moisturizer soothes itching associated with skin affected by eczema and atopic dermatitis.

14 Sep 2010

Lakeland second-quarter revenue increases 6.5% to $24.6 million

Lakeland Industries, Inc. today announced financial results for its second quarter fiscal year 2011 ended July 31, 2010.

14 Sep 2010

Planet Beach launches lower investment version of Contempo Spa franchise

Planet Beach Franchising Corporation, a recognizable leader in the health, wellness and beauty industry, has launched a lower investment version of its successful Contempo Spa franchise.

14 Sep 2010

Parents struggle to balance emotional, rational aspects of immunization: Poll

Back-to-school is in full swing and parents are breathing a collective sigh of relief now that their kids are back in the classroom. But with the back-to-school rush comes the reminder that immunizations must be updated - and that thought has parents filled with anything but relief. In fact, according to a new poll of Ontarians, parents struggle emotionally with immunizing their children - and themselves - before making the decision to do so.

14 Sep 2010

Target shoppers can help St. Jude's in fight against cancer, catastrophic diseases

Many of the public's favorite household brands have joined forces to support the lifesaving work of St. Jude Children's Research Hospital, one of the world's premier pediatric cancer research centers. From September 19 - 25, Target guests can help St. Jude in its fight to find cures and save children with cancer and other catastrophic diseases by purchasing participating Procter & Gamble (P&G) brands including Tide, Charmin, Bounty and Pampers as well as other manufacturers' brands at Target stores nationwide.

14 Sep 2010

UBM Live anticipates CPhI Worldwide attendance to exceed 25,000

Leading events organiser UBM Live today announced that it expects the attendance for CPhI Worldwide, the annual flagship tradeshow for pharma ingredients, now in its 21st year and the year being held in Paris, to exceed the 25,000 seen at last year's event, held in Madrid.

14 Sep 2010

TeleHealth Services announces new partnership with TRHMC to improve patient experience

TeleHealth Services, the nation's leading provider of healthcare grade televisions and interactive patient education solutions, today announced a new partnership with The Reading Hospital and Medical Center. The 671-bed hospital chose TeleHealth Services as their interactive patient education and entertainment partner as an extension of the hospital's Surgical Care Improvement Project.

14 Sep 2010

CSC launches new educational program to enhance lymphoma patient, physician communication

The Cancer Support Community (CSC), uniting The Wellness Community and Gilda's Club Worldwide, announced today the launch of Framing Life With Lymphoma, a new educational program designed to enhance lymphoma patient and physician communication.

14 Sep 2010

GenVec completes initial milestone in collaboration with Novartis

GenVec, Inc. today announced that it has achieved the first milestone in its collaboration with Novartis, related to the development of treatments for hearing loss and balance disorders. The milestone was triggered by the successful completion of certain preclinical development activities.

14 Sep 2010

Life Technologies finalizes cell line license agreement for recombinant protein production

Life Technologies Corporation today announced that it has finalized cell line license agreements with a number of companies to provide rights to Life Technologies' proprietary CHO (Chinese hamster ovary) cell lines for the production of recombinant proteins used as therapeutic agents and vaccines.

14 Sep 2010

Data from Phase II trial of zanolimumab in PTCL published in British Journal of Haematology

TenX Biopharma, Inc. announced today that data from a Phase II trial of zanolimumab (HuMax-CD4®) in peripheral T-cell Lymphoma were published in the British Journal of Haematology (Sep 2010: 150(5):565-73). The Hx-CD4-109 trial was designed to evaluate the safety and efficacy of zanolimumab in patients who have relapsed or refractory non-cutaneous peripheral T-cell lymphoma.

14 Sep 2010

Gentium announces defibrotide presentations at 33rd World Congress of International Society of Hematology

Gentium S.p.A. today announced that two posters and one oral presentation on defibrotide will be presented at the 33rd World Congress of International Society of Hematology to be held at the ICC Jerusalem International Convention Center in Jerusalem, Israel, October 10-13, 2010.

14 Sep 2010

Stemedica Cell Technologies completes master bank of mesenchymal bone marrow-derived stem cells

Stemedica Cell Technologies, Inc., a world leader in adult stem cell manufacturing and research, announced today that it has completed its proprietary master bank of mesenchymal bone marrow-derived stem cells.

14 Sep 2010

Enrollment in Derma Sciences DSC127 Phase 2 trial in diabetic foot ulcer healing to conclude September end

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that patient screening in its DSC127 Phase 2 trial in diabetic foot ulcer healing will be completed tomorrow, and that enrollment in the trial will conclude on September 30. This randomized, double-blind, placebo controlled study of up to 75 patients will look at the percentage of diabetic ulcers completely healed over a 12-week period, among other outcomes.

14 Sep 2010

MedAssets announces agreement to purchase The Broadlane Group for $850M

MedAssets, Inc. today announced that it has entered into a definitive purchase agreement to acquire The Broadlane Group. Based in Dallas, Texas, The Broadlane Group is a leading provider of supply chain management, strategic sourcing of supplies and services, capital equipment lifecycle management, medical device or PPI cost management, centralized procurement, clinical and lean process consulting, and clinical workforce optimization.

14 Sep 2010

Tryton Medical closes $20 million Series D round of financing

Tryton Medical, Inc., the leading developer of stents designed to treat bifurcation lesions, today announced that the company has closed a $20 million Series D round of financing.

14 Sep 2010

First Edition: September 14, 2010

Among today's headlines, Berwick talks, health reform politics continue and coverage of the run up to Sept. 23 - the day several health overhaul provisions take effect - is in full swing.

14 Sep 2010

AstraZeneca Chief Scientist shares enthusiasm for collaborative clinical research

The pharmaceutical industry must ensure an improved record of delivery by providing high quality, cost effective solutions to well defined unmet needs. This can be achieved through strategic collaborations that strengthen disease knowledge and provide improved tools to strengthen therapeutic target validation and to monitor therapeutic efficacy, says Andy Dray, Chief Scientist at AstraZeneca.

14 Sep 2010

Stars join Bupa 30th Great North Run for Leukaemia & Lymphoma Research

Soap stars warm up for Bupa 30th Great North Run for Leukaemia & Lymphoma Research

14 Sep 2010

First Lady Michelle Obama to participate in the launch of CBCF Alumni Series

The Congressional Black Caucus Foundation, Inc., announced that First Lady Michelle Obama will participate in the launch of the CBCF Alumni Series as part of its 40th Annual Legislative Conference. The first of a three session series, "The ABCs of Healthy Student Learning: Addressing Disparities in Academic Achievement and Health" is scheduled from 1:30-3:30 p.m., September 15, at the Walter E. Washington Convention Center (Room 146-BC) and will feature remarks by the First Lady.

14 Sep 2010

Medical News

Cetaphil launches Restoraderm for management of eczema and atopic dermatitis skin

Lakeland second-quarter revenue increases 6.5% to $24.6 million

Planet Beach launches lower investment version of Contempo Spa franchise

Parents struggle to balance emotional, rational aspects of immunization: Poll

Target shoppers can help St. Jude's in fight against cancer, catastrophic diseases

UBM Live anticipates CPhI Worldwide attendance to exceed 25,000

TeleHealth Services announces new partnership with TRHMC to improve patient experience

CSC launches new educational program to enhance lymphoma patient, physician communication

GenVec completes initial milestone in collaboration with Novartis

Life Technologies finalizes cell line license agreement for recombinant protein production

Data from Phase II trial of zanolimumab in PTCL published in British Journal of Haematology

Gentium announces defibrotide presentations at 33rd World Congress of International Society of Hematology

Stemedica Cell Technologies completes master bank of mesenchymal bone marrow-derived stem cells

Enrollment in Derma Sciences DSC127 Phase 2 trial in diabetic foot ulcer healing to conclude September end

MedAssets announces agreement to purchase The Broadlane Group for $850M

Tryton Medical closes $20 million Series D round of financing

First Edition: September 14, 2010

AstraZeneca Chief Scientist shares enthusiasm for collaborative clinical research

Stars join Bupa 30th Great North Run for Leukaemia & Lymphoma Research

First Lady Michelle Obama to participate in the launch of CBCF Alumni Series

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News